The data suggests that while the weight loss results are profound, the systemic impact on metabolic health requires a disciplined, professional approach to dosing and monitoring
Both medications share similar side effectsmainly nausea, vomiting, and diarrheathough retatrutide shows slightly higher rates of gastrointestinal issues in early studies
The standard weekly dosing works effectively across diverse patient populations
Weeks 5-8: 0.5 mg once weekly
Pharmacokinetic and clinical studies with levocarnitine injection have shown that administration of levocarnitine to ESRD patients on hemodialysis results in increased plasma levocarnitine concentrations
Yes, semaglutide can cause diarrhea, and in some cases, it may be severe